RGS2 and ovarian carcinoma: However, the expression of histone H3 in ovarian cancer cells are similar to those in the chemosensitive cells, indicating that the acetylational absence at RGS2 promoter leads to the deficiency of RGS2 expression in ovarian cancer cells with chemoresistance [25].